Showing results (41-50 of 5,314) with videos related to
Sort By:
Pageof 532
Journal of General Internal Medicine|June 25, 2016
Wearables, Smartphones and Novel Anticoagulants: We Will Treat More Atrial Fibrillation, but Will Patients Be Better Off?Adam Cifu, Vinay PrasadThe American Journal of Medicine|January 28, 2023
Comparability of Control and Comparison Groups in Studies Assessing Long COVIDAlyson Haslam, Vinay PrasadEuropean Journal of Clinical Investigation|July 17, 2022
Common misconceptions of randomized controlled trials in oncologyKerrington Powell, Vinay PrasadJournal of Cancer Research and Clinical Oncology|May 13, 2023
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLCAnushka Walia, Vinay PrasadEuropean Journal of Cancer (Oxford, England : 1990)|February 21, 2024
Equal censoring but still informative: When the reasons for censoring differ between treatment armsTimothée Olivier, Vinay PrasadContemporary Clinical Trials Communications|July 22, 2024
Publication of observational studies making claims of causation over timeAlyson Haslam, Vinay PrasadJournal of Cancer Policy|May 3, 2025
Minimal residual disease negative: A novel endpoint for accelerated approval; What providers should knowSruthi Ranganathan, Vinay PrasadJournal of Cancer Policy|March 10, 2025
Adding adjuvant drugs from distinct breast cancer trialsTimothée Olivier, Vinay PrasadTranslational Oncology|November 19, 2021
Elacestrant in metastatic breast cancer: Is the "standard of care" meeting standard requirements?Timothée Olivier, Vinay PrasadBMC Cancer|January 17, 2022
An estimate of rate of deviation from NCCN guideline recommendations for central nervous system imaging in trials forming basis for drug approval in first line advanced non-small cell lung cancer (NSCLC)John Sharp, Vinay PrasadPageof 532